The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex
Abstract
The deposition of the amyloid beta-protein (Abeta) is a pathological hallmark of Alzheimer's disease (AD). Abeta is a peptide consisting of 39-43 amino acids and is derived by beta- and gamma-secretase cleavage from the Abeta protein precursor (AbetaPP). An N-terminal-truncated form of Abeta can occur following alpha- and gamma-secretase cleavage of AbetaPP. Fleecy amyloid is a recently identified distinct type of Abeta deposits occurring in the internal layers (pri-alpha, pri-beta and pri-gamma) of the human entorhinal cortex. Fleecy amyloid consists exclusively of N-terminal-truncated Abeta and is a transient form of Abeta deposits, which disappears in late-stage beta-amyloidosis. In this study, the entorhinal cortex of 15 cases with AD-related pathology was used to examine astrocytes in the vicinity of N-terminal-truncated Abeta in fleecy amyloid of the layers pri-alpha, pri-beta, and pri-gamma in comparison to astrocytes in the vicinity of full-length Abeta in layers pre-beta and pre-gamma. Immunohistochemistry was performed with antibodies directed against AbetaPP, Abeta40, Abeta42, APbeta17-24, Abeta1-17 and Abeta8-17 as well as by double-labeling with antibodies directed against Abeta17-24, Abeta42, and glial fibrillary acid protein (GFAP). A large number of GFAP-positive astrocytes containing N-terminal-truncated Abeta fragments appeared in the vicinity of N-terminal-truncated Abeta, whereas Abeta-containing astrocytes were rarely seen in the vicinity of full-length A…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and Aβ has been observed in vesicles within astrocytes (57, 58).”
From Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice (2013) · cites this paper as [58]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citationHsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,075
The molecular pathology of Alzheimer's disease
Selkoe, D. J. (1991) · Neuron · doi:10.1016/0896-6273(91)90052-2 · Cited by 2,708
Amyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107
The Pathogenesis of Senile Plaques
DICKSON, D. W. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00001 · Cited by 753
Cell Biology of the Amyloid beta-Protein Precursor and the Mechanism of Alzheimer's Disease
Selkoe, D. J. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002105 · Cited by 748
Griffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S., McKenzie, J. E., Graham, D. I., Roberts, G. W., & Mrak, R. E. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 712
Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections
Braak, H., & Braak, E. (1991) · Brain Pathology · doi:10.1111/j.1750-3639.1991.tb00661.x · Cited by 598
Self-citationInterleukin-1 Expression in Different Plaque Types in Alzheimerʼs Disease
Griffin, W. S. T., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 546
Flagged first, then by citations
1 of the 32 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–137 of 137
Molecular Imaging of Neuroinflammation in Alzheimer’s Disease and Mild Cognitive Impairment
Kim, J., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_14 · Cited by 3
The many connections of UFMylation with Alzheimer’s disease: a comprehensive review
Yan, T., Clarkson, B. D. S., Lou, Z., Springer, W., & Fiesel, F. C. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00855-8 · Cited by 4
Bustos, L. M., & Sattler, R. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1075805 · Cited by 4
Human induced pluripotent stem cell– based modeling of Alzheimer’s disease, a glial perspective
Chen, X., Yang, Q., Liu, Z., & Shi, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00006-5 · Cited by 4
Apolipoprotein E (APOE) Isoforms and Neurobiology of Sporadic Alzheimer’s Disease
Mollica, A., Berardino, G., Bellomo, A., Altamura, M., Panza, F., & Lozupone, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_155-1 · Cited by 2
PET and the Multitracer Concept: An Approach to Neuroimaging Pathology
Engler, H. (2008) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 2
Astrocytic Activation Completely Corrects Memory Performance in an Alzheimer’s Disease ModelPreprint
Kreisel, T., Weinstein, Y., Groysman, M., Doron, A., Refaeli, R., London, M., & Goshen, I. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.29.679133 · Cited by 2
Udaiyappan, J. P., Balakrishnan, R., Tamilarasan, M. M., Balasubramanian, B., & Abass, K. S. (2026) · Inflammation · doi:10.1007/s10753-026-02492-9 · Cited by 3
Role of Reactive Astrocytes in Alzheimer’s Disease
Sarkar, S., Guha, S., & Biswas, S. C. (2022) · Springer eBooks · doi:10.1007/978-981-16-8313-8_9 · Cited by 1
Protective Effects of Cannabis in Neuroinflammation-Mediated Alzheimer's Disease
Kashif, M., Waseem, M., Vijendra, P. D., & Pandurangan, A. K. (2023) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5652-1.ch002 · Cited by 2
Preman, P., Julia, T. C. W., Calafate, S., Snellinx, A., Alfonso-Triguero, M., Corthout, N., Munck, S., Thal, D. R., Goate, A., Strooper, B. D., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-112937/v1 · Cited by 1
Self-citationGlial Cells and Aβ Peptides in Alzheimer’s Disease Pathogenesis
Siu, G., Clifford, P., Kosciuk, M. C., Venkataraman, V., & Nagele, R. G. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_13
Modulating Amyloid Beta Clearance by Altering Cellular and Whole Brain Apolipoprotein E Metabolism
Basak, J. M. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7dz06bk
Alzheimer's disease and dementia with Lewy bodies: Special focus on the role of serpins
Nielsen, H. M. (2007) · Lund University Publications (Lund University)
Alzheimer’s Disease Therapeutics Targeting Apolipoprotein E
Liao, F., & Holtzman, D. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00010-1
Munger, E. L. (2016) · OhioLink ETD Center (Ohio Library and Information Network)
Enhancing CNS Repair in Neurological Disease Arising from Neurodegeneration and
Xu, X., Warrington, A. E., Bieber, A. J., & Rodriguez, M. (2011)
Activation of Astrocytes in Neurodegenerative Diseases
Li, J., & Qin, S. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_3
Aβ-Induced Alterations in Membrane Lipids Occur before Synaptic Loss Appears
Bulck, M. V., Brandt, N., Claus, R. A., Gräler, M. H., & Bräuer, A. U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042300
(2007) · Elsevier eBooks · doi:10.1016/b978-012373657-4/50008-8
Apolipoprotein E (APOE) Isoforms and Neurobiology of Sporadic Alzheimer’s Disease
Mollica, A., Berardino, G., Bellomo, A., Altamura, M., Panza, F., & Lozupone, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_155
Zyśk, M., Beretta, C., Naia, L., Dakhel, A., Påvénius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023) · Figshare · doi:10.6084/m9.figshare.22610219
Zyśk, M., Beretta, C., Naia, L., Dakhel, A., Påvénius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023) · Figshare · doi:10.6084/m9.figshare.22610222
Swarbrick, S. (2019) · Loughborough University Research Repository (Loughborough University) · doi:10.26174/thesis.lboro.8272994
Zyśk, M., Beretta, C., Naia, L., Dakhel, A., Påvénius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023) · Figshare · doi:10.6084/m9.figshare.22610228
Zyśk, M., Beretta, C., Naia, L., Dakhel, A., Påvénius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023) · Figshare · doi:10.6084/m9.figshare.22610213
Preman, P., Julia, T. C. W., Calafate, S., Snellinx, A., Alfonso-Triguero, M., Corthout, N., Munck, S., Thal, D. R., Goate, A., Strooper, B. D., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16681657
Self-citationZyśk, M., Beretta, C., Naia, L., Dakhel, A., Påvénius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023) · Figshare · doi:10.6084/m9.figshare.22610210
Zyśk, M., Beretta, C., Naia, L., Dakhel, A., Påvénius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023) · Figshare · doi:10.6084/m9.figshare.22610216
Zyśk, M., Beretta, C., Naia, L., Dakhel, A., Påvénius, L., Brismar, H., Lindskog, M., Ankarcrona, M., & Erlandsson, A. (2023) · Figshare · doi:10.6084/m9.figshare.22610225
The Use of Localized Proteomics to Understand the Pathogenesis of Alzheimer's Disease
Pires, G. (2021) · theses.fr (ABES) · doi:10.70675/45826fd6zd2c8z4b3dz91e0za5080544cb17
Wu, F., & Wang, M. (2026) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlag098
Regulation and Pharmacological Manipulation of the Type 5 Metabotropic Glutamate (mGlu5) Receptor
Bradley, S. J. (2011) · Leicester Research Archive (University of Leicester)
Metadata
- Authors
- Thal, D. R., Schultz, C., Dehghani, F., Yamaguchi, H., Braak, H., & Braak, E.
- Affiliations
- Goethe University Frankfurt (DE)
- Gunma University (JP)
- Venue
- Acta Neuropathologica
- Published
- 2000-12-18
- Volume
- 100
- Issue
- 6
- Pages
- 608-617
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2087697089
- Cited by
- 136
- References
- 32
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 16 · 2022: 6 · 2021: 12 · 2020: 9 · 2019: 1 · 2018: 5 · 2017: 11 · 2016: 9 · 2015: 5 · 2014: 7 · 2013: 3 · 2012: 5
- FWCI
- 0.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Bundesministerium für Bildung und Forschung
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- amyloid-beta, entorhinal cortex, astrocytes, Alzheimer's disease, amyloid precursor protein, amyloid clearance, extracellular amyloid deposition, gamma-secretase, beta-secretase, glial fibrillary acidic protein
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Astrocytes, Female, Humans, Male, Middle Aged, Peptide Fragments, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Protein Structure, Tertiary, Entorhinal Cortex, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review